Binding Database

The following articles (labelled with PubMed ID or TBD) are for your review

PMID

Cmpds

Data

Article Title

Organization

Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma.

Setsunan University

Discovery of a potent, orally available dual CysLT1 and CysLT2 antagonist with dicarboxylic acid.

Ono Pharmaceutical

Discovery of Highly Potent Dual CysLT1 and CysLT2 Antagonist.

Ono Pharmaceutical

Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors.

Kyoto Prefectural University of Medicine

Fragment-based discovery of selective inhibitors of the Mycobacterium tuberculosis protein tyrosine phosphatase PtpA.

University Of California

Indazole containing macrocycles and therapeutic uses thereof

Samumed

Complement factor B inhibitors and uses there of

Novartis

Bicyclic nitrogen-containing aromatic heterocyclic amide compound

Astellas Pharma

Active Site Binding Is Not Sufficient for Reductive Deiodination by Iodotyrosine Deiodinase.

Johns Hopkins University

Synthesis and use of dual tyrosyl-DNA phosphodiesterase I (TDP1)- topoisomerase I (TOP1) inhibitors

Purdue Research Foundation

Hepatitis C virus NS3 protease is activated by low concentrations of protease inhibitors.

Uppsala University